BEN
55
2
AZO
42
-3
CI
48
-4
REGN
59
2
ESS
40
-5
MPC
38
2
D
41
-4
LMT
59
4
HSY
43
2
EOG
33
-3
ILMN
73
4
ALL
56
2
PFE
33
-8
BA
47
4
NVDA
54
5
PBI
68
2
ADM
47
2
VRTX
53
5
CA
30
3
STI
18
11
BEN
55
2
AZO
42
-3
CI
48
-4
REGN
59
2
ESS
40
-5
MPC
38
2
D
41
-4
LMT
59
4
HSY
43
2
EOG
33
-3
ILMN
73
4
ALL
56
2
PFE
33
-8
BA
47
4
NVDA
54
5
PBI
68
2
ADM
47
2
VRTX
53
5
CA
30
3
STI
18
11
Financhill
Back

STF Tactical Growth & Income ETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
41

TUGN
STF Tactical Growth & Income ETF

Last Price:
$25.64
Seasonality Move:
-1.93%
Sell
34

MNPR
Monopar Therapeutics, Inc.

Last Price:
$69.11
Seasonality Move:
25.93%
Sell
41
STF Tactical Growth & Income ETF (TUGN) is a Sell

Is STF Tactical Growth & Income ETF a Buy, Sell or Hold?

  • The current STF Tactical Growth & Income ETF [TUGN] share price is $25.65. The Score for TUGN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • TUGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TUGN Stock Price Chart

What is STF Tactical Growth & Income ETF's stock price today?

  • The STF Tactical Growth & Income ETF share price today is $25.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TUGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $68.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

TUGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.77 Buy
Relative Strength Index (14 RSI): 49.14 Sell
Chaikin Money Flow: 7677 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.3 - 25.9) Buy
Bollinger Bands (100): (25.14 - 26.24) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 166161 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.18 - 85.74) Sell
Bollinger Bands (100): (45.57 - 89.21) Buy

TUGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.55 Buy
20-day SMA: 25.64 Buy
50-day SMA: 25.91 Sell
200-day SMA: 24.3 Buy
8-day EMA: 13.45 Buy
20-day EMA: 6.58 Buy
50-day EMA: 2.87 Buy
200-day EMA: 0.75 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.35 Sell
20-day SMA: 78.65 Sell
50-day SMA: 81.47 Sell
200-day SMA: 52.32 Buy
8-day EMA: 71.44 Sell
20-day EMA: 75.9 Sell
50-day EMA: 76.79 Sell
200-day EMA: 56.68 Buy

STF Tactical Growth & Income ETF Earnings Growth & TUGN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

STF Tactical Growth & Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):